Clinical Trial: Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Two W

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of AzaSite ophthalmic solution, 1% on signs and symptoms of blepharitis.

Detailed Summary:
Sponsor: Merck Sharp & Dohme Corp.

Current Primary Outcome: Change in clinical signs and symptoms associated with blepharitis [ Time Frame: 2 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Standard ocular safety assessments [ Time Frame: 2 weeks ]

Original Secondary Outcome: Same as current

Information By: Merck Sharp & Dohme Corp.

Dates:
Date Received: February 21, 2008
Date Started: March 2008
Date Completion:
Last Updated: September 20, 2011
Last Verified: September 2011